These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1151605)

  • 21. In vitro release of hydrocortisone from topical preparations and automated procedure.
    Shah VP; Elkins J; Hanus J; Noorizadeh C; Skelly JP
    Pharm Res; 1991 Jan; 8(1):55-9. PubMed ID: 2014209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation.
    Savić S; Savić M; Tamburić S; Vuleta G; Vesić S; Müller-Goymann CC
    Eur J Pharm Sci; 2007 Apr; 30(5):441-50. PubMed ID: 17331708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gels and other topical corticosteroids.
    Med Lett Drugs Ther; 1974 Jun; 16(12):50-2. PubMed ID: 4831241
    [No Abstract]   [Full Text] [Related]  

  • 25. [Method for the identification and quantitative determination, by thin-layer chromatography, of clemizole in a combination ointment of hexachlorophene and hydrocortisone].
    Atay O; Türeli F; Celebioğlu A; Yazan Z
    Turk Hij Tecr Biyol Derg; 1978; 38(1-3):28-36. PubMed ID: 38545
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on the distribution of locally applied steroids in the eye].
    Draeger J
    Klin Monbl Augenheilkd; 1967; 150(4):546-9. PubMed ID: 5597900
    [No Abstract]   [Full Text] [Related]  

  • 27. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contact dermatitis to hydrocortisone aceponate in Efficort cream inducing widespread reaction.
    El Sayed F; Ammoury A; Launais F; Bazex J
    Contact Dermatitis; 2005 Oct; 53(4):242-3. PubMed ID: 16191032
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulation of drug transport properties by multicomponent diffusion in surfactant aqueous solutions.
    Zhang H; Annunziata O
    Langmuir; 2008 Oct; 24(19):10680-7. PubMed ID: 18717577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine.
    Baboota S; Shakeel F; Kohli K
    Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):109-14. PubMed ID: 16636721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of thyme extract in the prescription of dental gels produced on Carbopol base].
    Kołodziejska J; Berner-Strzelczyk A; Piechota-Urbańska M
    Polim Med; 2009; 39(2):31-8. PubMed ID: 19708499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of certain physico-chemical parameters as a guide toward the relative globul anticipation of the rate of diffusion of an active substance dissolved in gels having a Carbopol base].
    Lhoest G
    Pharm Acta Helv; 1973 Oct; 48(10):549-69. PubMed ID: 4771010
    [No Abstract]   [Full Text] [Related]  

  • 34. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation.
    Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
    Quan DQ; Xu GX
    Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparations of hydrocortisone associated with an antibiotic for dermatological use].
    Clin Ter; 1966 Aug; 38(4):382-5. PubMed ID: 5990201
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of sprained ankles. A double-blind study.
    Lester AA
    Practitioner; 1981 Jun; 225(1356):935-6. PubMed ID: 7029509
    [No Abstract]   [Full Text] [Related]  

  • 38. Design of the optimal topical system for fluocinonide.
    Reinstein J; Ostrenga J; Haleblian J; Shastri S; Poulsen B; Katz M
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):Suppl 67:13-8. PubMed ID: 5291642
    [No Abstract]   [Full Text] [Related]  

  • 39. Tetronic micellization, gelation and drug solubilization: Influence of pH and ionic strength.
    Alvarez-Lorenzo C; Gonzalez-Lopez J; Fernandez-Tarrio M; Sandez-Macho I; Concheiro A
    Eur J Pharm Biopharm; 2007 May; 66(2):244-52. PubMed ID: 17123799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants.
    El Maghraby GM
    Int J Pharm; 2008 May; 355(1-2):285-92. PubMed ID: 18243604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.